MX2020013347A - Polimerasas, composiciones y metodos de uso. - Google Patents

Polimerasas, composiciones y metodos de uso.

Info

Publication number
MX2020013347A
MX2020013347A MX2020013347A MX2020013347A MX2020013347A MX 2020013347 A MX2020013347 A MX 2020013347A MX 2020013347 A MX2020013347 A MX 2020013347A MX 2020013347 A MX2020013347 A MX 2020013347A MX 2020013347 A MX2020013347 A MX 2020013347A
Authority
MX
Mexico
Prior art keywords
methods
polymerases
compositions
incorporation
altered
Prior art date
Application number
MX2020013347A
Other languages
English (en)
Inventor
Misha Golynskiy
Seth Mcdonald
Saurabh Nirantar
Matthew Kellinger
Michael Previte
Sergio Peisajovich
Molly He
Original Assignee
Illumina Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Illumina Inc filed Critical Illumina Inc
Publication of MX2020013347A publication Critical patent/MX2020013347A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07—Nucleotidyltransferases (2.7.7)
    • C12Y207/07007—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1252—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00—Reaction characterised by the enzymatic activity
    • C12Q2521/10—Nucleotidyl transfering
    • C12Q2521/101—DNA polymerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence

Abstract

En la presente se presentan enzimas de polimerasa alteradas para la incorporación mejorada de nucleótidos y análogos de nucleótidos, en particular polimerasas alteradas que mantienen alta fidelidad bajo tiempos de incorporación reducidos, así como métodos y kits que utilizan los mismos.
MX2020013347A 2018-10-31 2019-10-31 Polimerasas, composiciones y metodos de uso. MX2020013347A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862753558P 2018-10-31 2018-10-31
PCT/US2019/059246 WO2020092830A1 (en) 2018-10-31 2019-10-31 Polymerases, compositions, and methods of use

Publications (1)

Publication Number Publication Date
MX2020013347A true MX2020013347A (es) 2021-04-28

Family

ID=68621372

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020013347A MX2020013347A (es) 2018-10-31 2019-10-31 Polimerasas, composiciones y metodos de uso.

Country Status (13)

Country Link
US (3) US11104888B2 (es)
EP (1) EP3874036A1 (es)
JP (1) JP2022503427A (es)
KR (1) KR20210084349A (es)
CN (1) CN112673098B (es)
AU (1) AU2019374098A1 (es)
BR (1) BR112020026658A2 (es)
CA (1) CA3103719A1 (es)
IL (2) IL299237A (es)
MX (1) MX2020013347A (es)
SG (1) SG11202012493WA (es)
WO (1) WO2020092830A1 (es)
ZA (1) ZA202007838B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020013347A (es) 2018-10-31 2021-04-28 Illumina Inc Polimerasas, composiciones y metodos de uso.
WO2020117968A2 (en) 2018-12-05 2020-06-11 Illumina, Inc. Polymerases, compositions, and methods of use
US11293061B2 (en) 2018-12-26 2022-04-05 Illumina Cambridge Limited Sequencing methods using nucleotides with 3′ AOM blocking group
AU2020412459B2 (en) 2019-12-23 2022-12-08 Singular Genomics Systems, Inc. Methods for long read sequencing
CA3166578A1 (en) 2019-12-31 2021-07-08 Singular Genomics Systems, Inc. Polynucleotide barcodes for long read sequencing
EP4117682A4 (en) 2020-04-24 2023-09-13 Singular Genomics Systems, Inc. MODIFIED NUCLEOTIDES AND THEIR USES
MA58991A1 (fr) 2020-06-22 2023-03-31 Illumina Cambridge Ltd Nucléosides et nucléotides avec groupe de blocage acétal 3'
US20220195516A1 (en) 2020-12-17 2022-06-23 Illumina Cambridge Limited Methods, systems and compositions for nucleic acid sequencing
US20220195518A1 (en) 2020-12-22 2022-06-23 Illumina Cambridge Limited Methods and compositions for nucleic acid sequencing
EP4334327A1 (en) 2021-05-05 2024-03-13 Illumina Cambridge Limited Fluorescent dyes containing bis-boron fused heterocycles and uses in sequencing
KR20240009435A (ko) 2021-05-20 2024-01-22 일루미나, 인코포레이티드 합성에 의한 시퀀싱을 위한 조성물 및 방법
US20230265402A1 (en) 2022-02-18 2023-08-24 Element Biosciences, Inc. Engineered polymerases with reduced sequence-specific errors
WO2023186815A1 (en) 2022-03-28 2023-10-05 Illumina Cambridge Limited Labeled avidin and methods for sequencing
US20230313292A1 (en) 2022-03-29 2023-10-05 Illumina Cambridge Limited Chromenoquinoline dyes and uses in sequencing
AU2023246691A1 (en) 2022-03-30 2024-01-18 Illumina, Inc. Methods for chemical cleavage of surface-bound polynucleotides
CA3223128A1 (en) 2022-03-31 2023-10-05 Illumina, Inc. Compositions and methods for improving sequencing signals
WO2023192900A1 (en) 2022-03-31 2023-10-05 Illumina Singapore Pte. Ltd. Nucleosides and nucleotides with 3' vinyl blocking group useful in sequencing by synthesis
WO2023232829A1 (en) 2022-05-31 2023-12-07 Illumina, Inc Compositions and methods for nucleic acid sequencing
WO2024003087A1 (en) 2022-06-28 2024-01-04 Illumina, Inc. Fluorescent dyes containing fused tetracyclic bis-boron heterocycle and uses in sequencing
WO2024068971A1 (en) 2022-09-30 2024-04-04 Illumina, Inc. Polymerases, compositions, and methods of use
WO2024068889A2 (en) 2022-09-30 2024-04-04 Illumina, Inc. Compositions and methods for reducing photo damage during sequencing

Family Cites Families (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2044616A1 (en) 1989-10-26 1991-04-27 Roger Y. Tsien Dna sequencing
US5756334A (en) 1990-04-26 1998-05-26 New England Biolabs, Inc. Thermostable DNA polymerase from 9°N-7 and methods for producing the same
WO1997039150A1 (en) 1996-04-15 1997-10-23 University Of Southern California Synthesis of fluorophore-labeled dna
DE69725076T2 (de) 1996-07-29 2004-04-15 Toyo Boseki K.K. Modifizierte thermostabile DNA Polymerase und eine DNA Polymerasezusammensetzung zur Amplifikation von Nukleinsäuren
GB9620209D0 (en) 1996-09-27 1996-11-13 Cemu Bioteknik Ab Method of sequencing DNA
GB9626815D0 (en) 1996-12-23 1997-02-12 Cemu Bioteknik Ab Method of sequencing DNA
US6228628B1 (en) 1997-07-09 2001-05-08 Roche Molecular Systems Mutant chimeric DNA polymerase
US5882904A (en) 1997-08-04 1999-03-16 Amersham Pharmacia Biotech Inc. Thermococcus barossii DNA polymerase mutants
US5948666A (en) 1997-08-06 1999-09-07 Diversa Corporation Isolation and identification of polymerases
US20050191698A1 (en) 1999-04-20 2005-09-01 Illumina, Inc. Nucleic acid sequencing using microsphere arrays
JP4150166B2 (ja) 1999-05-07 2008-09-17 ロシュ ダイアグノスティックス ゲーエムベーハー 修飾ヌクレオチドまたは発色団を有するヌクレオチドとｄｎａポリメラーゼを使用するｄｎａの高密度標識
US6492161B1 (en) 1999-06-02 2002-12-10 Prokaria Ltd. Bacteriophage RM 378 of a thermophilic host organism
US7244559B2 (en) 1999-09-16 2007-07-17 454 Life Sciences Corporation Method of sequencing a nucleic acid
US6274320B1 (en) 1999-09-16 2001-08-14 Curagen Corporation Method of sequencing a nucleic acid
JP2003510063A (ja) 1999-09-30 2003-03-18 ニュー・イングランド・バイオラブズ・インコーポレイティッド 古細菌のｄｎａポリメラーゼによる修飾ヌクレオチドの取り込み及びそれに関する方法
US8268605B2 (en) 1999-10-29 2012-09-18 Agilent Technologies, Inc. Compositions and methods utilizing DNA polymerases
WO2001032887A1 (en) 1999-10-29 2001-05-10 Stratagene Compositions and methods utilizing dna polymerases
US20030228616A1 (en) 1999-10-29 2003-12-11 Stratagene DNA polymerase mutants with reverse transcriptase activity
US6333183B1 (en) 1999-11-23 2001-12-25 Amersham Pharmacia Biotech, Inc. Dideoxynucleotide-triphosphate utilization by the hyper-thermophilic DNA polymerase from the archaeon Pyrococcus furiosus
US6329178B1 (en) 2000-01-14 2001-12-11 University Of Washington DNA polymerase mutant having one or more mutations in the active site
AU2007201277B2 (en) 2000-05-24 2011-10-13 Third Wave Technologies, Inc. Detection of RNA
EP1975251A3 (en) 2000-07-07 2009-03-25 Visigen Biotechnologies, Inc. Real-time sequence determination
US20020102577A1 (en) 2000-07-31 2002-08-01 Raillard Sun Ai Nucleotide incorporating enzymes
EP1354064A2 (en) 2000-12-01 2003-10-22 Visigen Biotechnologies, Inc. Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity
CA2450139A1 (en) 2001-06-11 2002-12-19 Illumina, Inc Multiplexed detection methods
US7057026B2 (en) 2001-12-04 2006-06-06 Solexa Limited Labelled nucleotides
ES2407681T3 (es) 2002-08-23 2013-06-13 Illumina Cambridge Limited Nucleótidos modificados para la secuenciación de polinucleótidos.
US7595883B1 (en) 2002-09-16 2009-09-29 The Board Of Trustees Of The Leland Stanford Junior University Biological analysis arrangement and approach therefor
US8283148B2 (en) 2002-10-25 2012-10-09 Agilent Technologies, Inc. DNA polymerase compositions for quantitative PCR and methods thereof
GB0321306D0 (en) 2003-09-11 2003-10-15 Solexa Ltd Modified polymerases for improved incorporation of nucleotide analogues
CA2579150C (en) 2004-09-17 2014-11-25 Pacific Biosciences Of California, Inc. Apparatus and method for analysis of molecules
US20070048748A1 (en) 2004-09-24 2007-03-01 Li-Cor, Inc. Mutant polymerases for sequencing and genotyping
JP4990886B2 (ja) 2005-05-10 2012-08-01 ソレックサ リミテッド 改良ポリメラーゼ
US7405281B2 (en) 2005-09-29 2008-07-29 Pacific Biosciences Of California, Inc. Fluorescent nucleotide analogs and uses therefor
AU2006330947B2 (en) 2005-12-22 2012-04-12 Pacific Biosciences Of California, Inc. Polymerases for nucleotide analogue incorporation
EP3373174A1 (en) 2006-03-31 2018-09-12 Illumina, Inc. Systems and devices for sequence by synthesis analysis
WO2008006781A2 (en) 2006-07-14 2008-01-17 Novozymes A/S Polypeptides having lipase activity and polynucleotides encoding same
GB0617575D0 (en) 2006-09-06 2006-10-18 Syngenta Ltd Herbicidal compounds and compositions
US8435775B2 (en) 2006-09-06 2013-05-07 Medical Research Council Mutant Pfu DNA polymerase
WO2008051530A2 (en) 2006-10-23 2008-05-02 Pacific Biosciences Of California, Inc. Polymerase enzymes and reagents for enhanced nucleic acid sequencing
US8262900B2 (en) 2006-12-14 2012-09-11 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8349167B2 (en) 2006-12-14 2013-01-08 Life Technologies Corporation Methods and apparatus for detecting molecular interactions using FET arrays
EP4134667A1 (en) 2006-12-14 2023-02-15 Life Technologies Corporation Apparatus for measuring analytes using fet arrays
EP2097523B1 (en) 2006-12-29 2014-10-29 Agilent Technologies, Inc. Compositions and methods using split polymerases
EP2231878B1 (en) 2007-12-27 2012-12-26 GE Healthcare Bio-Sciences Corp. A single enzyme system for fast, ultra long pcr
US20110045489A1 (en) 2008-04-22 2011-02-24 New England Biolabs, Inc. Polymerases for Incorporating Modified Nucleotides
US20100137143A1 (en) 2008-10-22 2010-06-03 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
US8481685B2 (en) 2008-11-03 2013-07-09 Kapa Biosystems Modified DNA polymerases
US9243272B2 (en) 2009-01-15 2016-01-26 Hokkaido Mitsui Chemicals Inc. Enzyme preparation containing thermostable DNA polymerase, method for producing same, and method for detecting subject organism to be detected
WO2011026194A1 (en) 2009-09-07 2011-03-10 Reproductive Health Science Pty Ltd Nucleic acid extraction
US8965076B2 (en) 2010-01-13 2015-02-24 Illumina, Inc. Data processing system and methods
US20110301041A1 (en) 2010-02-26 2011-12-08 Life Technologies Corporation Modified Proteins and Methods of Making and Using Same
GB201007384D0 (en) 2010-04-30 2010-06-16 Medical Res Council Enzymes
WO2012058096A1 (en) 2010-10-27 2012-05-03 Illumina, Inc. Microdevices and biosensor cartridges for biological or chemical analysis and systems and methods for the same
US8921044B2 (en) 2011-05-11 2014-12-30 New England Biolabs, Inc. DNA polymerase variants with reduced exonuclease activity and uses thereof
EP2707481B1 (en) 2011-05-11 2016-07-13 New England Biolabs, Inc. Dna polymerase variants with reduced exonuclease activity and uses thereof
WO2014142921A1 (en) 2013-03-14 2014-09-18 Illumina, Inc. Modified polymerases for improved incorporation of nucleotide analogues
GB2526261B (en) 2014-04-28 2017-08-02 Gelliner Ltd Encoded cells and cell arrays
US9765309B2 (en) 2014-06-27 2017-09-19 Illumina, Inc. Modified polymerases for improved incorporation of nucleotide analogues
EP3450558B1 (en) 2014-08-27 2020-09-30 New England Biolabs, Inc. Synthon formation
EP3201355B1 (en) 2014-09-30 2019-07-31 Illumina, Inc. Modified polymerases for improved incorporation of nucleotide analogues
US20200231947A1 (en) 2015-09-09 2020-07-23 Qiagen Gmbh Polymerase enzyme
US10662413B2 (en) 2016-11-01 2020-05-26 Personal Genomics, Inc. Recombinant DNA polymerase for improved incorporation of nucleotide analogues
WO2018126470A1 (zh) 2017-01-09 2018-07-12 深圳华大智造科技有限公司 重组dna聚合酶
US20200002689A1 (en) 2017-02-13 2020-01-02 Qiagen Sciences, Llc Polymerase enzyme from 9°n
WO2018148724A1 (en) 2017-02-13 2018-08-16 Qiagen Waltham Inc. Polymerase enzyme from pyrococcus furiosus
WO2018148723A1 (en) 2017-02-13 2018-08-16 Qiagen Waltham Inc. Polymerase enzyme from pyrococcus abyssi
WO2018148727A1 (en) 2017-02-13 2018-08-16 Qiagen Waltham Inc. Polymerase enzyme from 9°n
WO2018148726A1 (en) 2017-02-13 2018-08-16 Qiagen Waltham Inc. Polymerase enzyme from phage t4
US20210324353A1 (en) 2018-09-03 2021-10-21 Bgi Shenzhen Recombinant kod polymerase
EP3850110A4 (en) 2018-09-11 2022-06-08 Singular Genomics Systems, Inc. MODIFIED ARCHAEA FAMILY B POLYMERASES
US10731141B2 (en) 2018-09-17 2020-08-04 Omniome, Inc. Engineered polymerases for improved sequencing
MX2020013347A (es) * 2018-10-31 2021-04-28 Illumina Inc Polimerasas, composiciones y metodos de uso.
WO2020117968A2 (en) 2018-12-05 2020-06-11 Illumina, Inc. Polymerases, compositions, and methods of use

Also Published As

Publication number Publication date
BR112020026658A2 (pt) 2021-08-10
AU2019374098A1 (en) 2021-01-07
US20230212534A1 (en) 2023-07-06
CA3103719A1 (en) 2020-05-07
WO2020092830A1 (en) 2020-05-07
IL279422A (en) 2021-01-31
SG11202012493WA (en) 2021-01-28
KR20210084349A (ko) 2021-07-07
CN112673098A (zh) 2021-04-16
IL279422B2 (en) 2023-05-01
US11560552B2 (en) 2023-01-24
US20220056424A1 (en) 2022-02-24
IL279422B1 (en) 2023-01-01
US11104888B2 (en) 2021-08-31
CN112673098B (zh) 2023-01-06
JP2022503427A (ja) 2022-01-12
ZA202007838B (en) 2023-04-26
EP3874036A1 (en) 2021-09-08
US20200131484A1 (en) 2020-04-30
IL299237A (en) 2023-02-01

Similar Documents

Publication Publication Date Title
MX2020013357A (es) Polimerasas, composiciones y metodos de uso.
MX2020013347A (es) Polimerasas, composiciones y metodos de uso.
MX2022004101A (es) Composiciones de oligonucleotidos y metodos de uso de las mismas.
MX2018014890A (es) Composiciones de limpieza que comprenden enzimas.
EP4265261A3 (en) Methods and compositions for inhibiting expression of ldha
PH12021550805A1 (en) Methods and Compositions for Editing RNAs
EP4249074A3 (en) Genomic engineering of pluripotent cells
CR20200192A (es) Métodos y composiciones para la producción de nucleósido trifosfatos y ácidos ribonucleicos
WO2015112767A3 (en) Novel reverse transcriptases for use in high temperature nucleic acid synthesis
BR112016026950A2 (pt) composições de rnai para angiotensinogênio (agt) e métodos de uso das mesmas
PH12019500626A1 (en) Aav treatment of huntington's disease
PH12021550686A1 (en) Compositions and methods for lactate dehydrogenase (ldha) gene editing
WO2015081229A3 (en) Selective amplification of nucleic acid sequences
EP3882343A3 (en) Thermostable variants of t7 rna polymerase
MX2021013581A (es) Composiciones de nanoemulsiones que comprenden ingredientes biologicamente activos.
MX2019015188A (es) Inserciones de adn no virales orientadas.
WO2016100438A3 (en) Polymerase compositions and methods of making and using same
MX2020014248A (es) Composiciones y metodos para edicion genomica mediante insercion de polinucleotidos donadores.
PH12020550654A1 (en) Asymmetric pcr methods
WO2020030984A3 (en) Compositions and methods for genome engineering with cas12a proteins
EP4292651A3 (en) Liponucleotide-based therapy for ards
MX2019005101A (es) Microarns modificados con 5-halouracilo y su uso en el tratamiento del cancer.
WO2019226939A8 (en) Immune checkpoint inhibitor co-expression vectors
IL292053A (en) Preparations, methods and kits for stabilizing a biological sample and RNA
MX2019006552A (es) Terapia génica para mucopolisacaridosis de tipo i.